COLLABORATIONS 2017-10-24T20:46:16+00:00

Evotec

Evotec is a leading global drug discovery partnership organization with expertise in multiple therapeutics areas including infectious disease. Forge & Evotec formed a strategic relationship in 2016 to advance the LpxC program and expanded in 2017 to further develop the BLACKSMITH platform. In addition, Evotec is an investor in Forge’s Series A financing.

evotec.com

Syngene International

Forge partners with Syngene on select chemistry activities including analoging, building block synthesis, and scale-up. Syngene is India’s largest contract research organization.

www.syngeneintl.com

CARB-X

CARB-X is the world’s largest public-private partnership dedicated to supporting the discovery of antibiotics targeting Gram-negative bacteria. CARB-X has over $450M in funding to support a portfolio of new innovative drug discovery programs. Forge was the largest recipient of the inagural CARB-X awards.

carb-x.org

NIH/NIAID 

Forge has been collaborating with NIAID since 2015 to develop key datasets to help advance its anti-infective programs.

nih.gov

USAMRIID

Forge has initiated a collaboration with USAMRIID to investigate medical counter measures for biodefense.

usamriid.army.mil

USC/Spellberg

Forge is collaborating with Dr. Spellberg on the development of antibiotics to treat multi (MDR) and extensively drug resistant (XDR) bacteria infections.

keck.usc.edu/faculty/brad-spellberg/